Paper2014965
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Potel G and 9 others. Antimicrob Agents Chemother, 1991. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. Papers, record 2014965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2014965
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Endocarditis, Bacterial | Major topic |
| Enterobacteriaceae Infections | Major topic |
| Gentamicins | Major topic |
| Serratia marcescens | Major topic |
| Tobramycin | Major topic |
| Animals | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Infusions, Intravenous | |
| Microbial Sensitivity Tests | |
| Rabbits |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5123055 | Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. | Yale J Biol Med | 1971 | https://conductscience.org/library/papers/5123055 | PubMed |
| 2 | 2111658 | Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2111658 | PubMed |
| 3 | 7044303 | Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7044303 | PubMed |
| 4 | 6842025 | Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6842025 | PubMed |
| 5 | 6526736 | The acetylation of 6'-amino group of amikacin by a new enzyme prepared from serratia sp. | J Antibiot (Tokyo) | 1984 | https://conductscience.org/library/papers/6526736 | PubMed |
| 6 | 3512733 | Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3512733 | PubMed |
| 7 | 263882 | Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/263882 | PubMed |
| 8 | 3540140 | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. | J Infect Dis | 1987 | https://conductscience.org/library/papers/3540140 | PubMed |
| 9 | 3106301 | Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method. | J Antimicrob Chemother | 1987 | https://conductscience.org/library/papers/3106301 | PubMed |
| 10 | 3302848 | [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin]. | Pathol Biol (Paris) | 1987 | https://conductscience.org/library/papers/3302848 | PubMed |
| 11 | 3325794 | Bacterial uptake of aminoglycoside antibiotics. | Microbiol Rev | 1987 | https://conductscience.org/library/papers/3325794 | PubMed |
| 12 | 3282748 | Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3282748 | PubMed |
| 13 | 3392422 | Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3392422 | PubMed |
| 14 | 2850910 | Antibiotic uptake into gram-negative bacteria. | Eur J Clin Microbiol Infect Dis | 1988 | https://conductscience.org/library/papers/2850910 | PubMed |
| 15 | 2644371 | Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. | J Infect Dis | 1989 | https://conductscience.org/library/papers/2644371 | PubMed |
| 16 | 2523432 | Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. | J Infect Dis | 1989 | https://conductscience.org/library/papers/2523432 | PubMed |
| 17 | 2665645 | Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2665645 | PubMed |
| 18 | 2684011 | Aminoglycoside uptake increased by tet gene expression. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2684011 | PubMed |
| 19 | 2108113 | Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2108113 | PubMed |
| 20 | 2186909 | Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections. | Eur J Clin Microbiol Infect Dis | 1990 | https://conductscience.org/library/papers/2186909 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33599221 | Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections. | Nanoscale Horiz | 2021 | https://conductscience.org/library/papers/33599221 | PubMed |
| 14576143 | Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14576143 | PubMed |
| 8849249 | Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8849249 | PubMed |
| 8837524 | A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro. | Bull Math Biol | 1996 | https://conductscience.org/library/papers/8837524 | PubMed |
| 7955770 | What is the evidence for once-daily aminoglycoside therapy? | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7955770 | PubMed |
| 7521830 | Parenteral aminoglycoside therapy. Selection, administration and monitoring. | Drugs | 1994 | https://conductscience.org/library/papers/7521830 | PubMed |
| 1759831 | Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1759831 | PubMed |
| 1503436 | Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1503436 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2014965
GET https://conductscience.org/api/papers/v1/2014965/references?page=2